Treatment Registry
TR-1094 ActiveRecorded October 2026

Dulaglutide

Sold by JumpstartMD · every dulaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit JumpstartMD

We earn nothing from this link. It opens JumpstartMD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

Sourcing and terms

PharmacyNot disclosed
StatesCalifornia
PrescriberNot disclosed
CancellationNot disclosed
MembershipRequired. Amount not published. Medication is prescribed as part of membership, and medication costs are not included in membership fees; no ongoing care fee is published in the reviewed public pages. https://jumpstartmd.com/faq/ https://jumpstartmd.com/insurance/
Consult feeNot disclosed

Recorded from jumpstartmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — JumpstartMD lists clinician-selected prescription options as part of its supervised membership. The public catalog names Ozempic, Wegovy, oral Wegovy, Rybelsus, Zepbound, Mounjaro, Saxenda and Trulicity; the dedicated Foundayo page explicitly says its clinicians prescribe orforglipron. Ingredient overview pages are not evidence of a separate compounded program. https://jumpstartmd.com/weight-loss-medications/ https://jumpstartmd.com/weight-loss-medication-foundayo/
  2. 2. October 2026 — Medication costs are not included in membership fees. The public pages advertise a limited-time $99 getting-started offer, previously $379, without establishing the ongoing membership amount or complete first invoice. Retail estimates and manufacturer savings as low as $25 are not JumpstartMD drug prices or universally available invoices. https://jumpstartmd.com/faq/ https://jumpstartmd.com/insurance/ https://jumpstartmd.com/weight-loss-medication-mounjaro/ https://jumpstartmd.com/weight-loss-medication-zepbound/
  3. 3. October 2026 — The service describes California clinics and online appointments for members throughout California. Treatment remains subject to clinical eligibility. Quest is a laboratory partner, not a dispensing pharmacy. Patients can use a pharmacy of choice or an unnamed partner pharmacy; no individual dispenser is assigned. https://jumpstartmd.com/locations/ https://jumpstartmd.com/online-care/ https://jumpstartmd.com/faq/
  4. 4. October 2026 — The medication-specific public source for this record is https://jumpstartmd.com/weight-loss-medications/ . The catalog supports the named offering; no dose, device or additional route is inferred from manufacturer knowledge. Oral Wegovy and Foundayo are called pills, while Rybelsus is explicitly called a tablet. The oral Wegovy page does not specify tablet versus capsule; Rybelsus explicitly names tablets.
  5. 5. October 2026 — The practice offers in-person and online clinician appointments, laboratory review and health coaching. The reviewed public pages do not establish one universal mandatory video versus asynchronous prescribing modality. Website Terms of Use are not a published patient medication-refund or membership-renewal policy. https://jumpstartmd.com/online-care/ https://jumpstartmd.com/terms-of-use/

7 further notes concern other JumpstartMD programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1094
Medication category
dulaglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). JumpstartMD — dulaglutide (TR-1094). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1094

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.